Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection
Guangqiang Meng, Jingshi Wang, Yini Wang, Na Wei, Zhao Wang
Topics & Concepts
Hemophagocytic lymphohistiocytosisRituximabImmunologyPeripheral blood mononuclear cellMedicineHematopoietic stem cell transplantationEpstein–Barr virusLymphomaVirologyChemotherapyVirusTransplantationBiologyInternal medicineIn vitroDiseaseBiochemistryAutoimmune and Inflammatory Disorders ResearchParvovirus B19 Infection StudiesViral-associated cancers and disorders